Alterations in the Placenta Following Vaccination and Infection with SARS-CoV-2 During Pregnancy

Nils Hoymann1,2, Laura Scholz1,2, Suzan Alboradi1,2

  • 1Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University, 39108 Magdeburg, Germany.

Despite the years that have passed since the pandemic, data regarding the effects of mild SARS-CoV-2 infection and vaccination during pregnancy remain limited. The current study investigated the expression of molecules that may be involved in the placental immune response using real-time PCR and Western blot analysis in a well-characterized cohort of 118 placentas collected between the 37th and 40th week of gestation. Secreted mediators were assessed in the supernatant of placental cell cultures, and histological examinations of the placental tissue were performed. Significant differences in the expression levels of S100B, IL6, and CCL5 were observed in control versus vaccinated and previously infected women, as determined by PCR. Acute SARS-CoV-2 infection decreased the expression of p38 MAPK and Bcl-2 compared to control patients. The secretion of G-CSF, IFN-α2, IL-2, and CXCL8 (IL-8) increased in women who were infected during pregnancy and/or vaccinated. However, histological analysis revealed only minor differences between the groups. In conclusion, SARS-CoV-2 infection or vaccination during pregnancy induced a measurable placental immune response that remained below the threshold of histologically detectable tissue injury.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview